TB

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 62. Control and Eradication
2. 55. Drug Resistance
   1. Agenda for Action
   2. Implementation of Strategies: Two Lessons from Experience
   3. Interventions
   4. Risk Factors
3. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
   1. Issues for the Future
   2. Procurement of Drugs
   3. Selection of Drugs
   4. The WHO Prequalification Schemes
   5. Vaccine Research Priorities
4. 12. Financing Health Systems in the 21st Century
   1. Health Financing Issues in LICs
   2. Health Financing Systems
5. 8. Improving the Health of Populations: Lessons of Experience
   1. Cases
6. 2. Intervention Cost–Effectiveness: Overview of Main Messages
   1. Discussion
7. 1. Investing in Health
   1. Annex 1.A: The Burden of Disease in 2001
8. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
   1. Costing and Financing Additional Spending for the MDGs
9. 60. Occupational Health
   1. Nature and Causes of Occupational Health Conditions in the Developing World
10. 4. Priorities for Global Research and Development of Interventions
11. 6. Product Development Priorities
    1. Diagnostics
    2. Financing and Institutional Arrangements for New Product Development
    3. Introduction
    4. Regulatory and Liability Issues
12. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Conclusions
    2. Making Development Assistance for Health More Effective: Lessons Learned
13. 35. Respiratory Diseases of Adults
    1. Acute Diseases: Pneumonia and Influenza
    2. Chronic Respiratory Diseases: Nature, Causes, and Burden
    3. Future Research Needs
    4. General Approach to Lowering Risk of Adult Respiratory Disease
    5. Occupational Lung Disease and Other Respiratory Diseases
14. 16. Tuberculosis
    1. Acknowledgments
    2. Alternative and Complementary Approaches to the Diagnosis and Treatment of Active Disease
    3. Conclusions
    4. Cost-Effectiveness of Interventions against Tuberculosis
    5. Cost-Effectiveness of Managing Endemic Tuberculosis
    6. Cost-Effectiveness of Managing Tuberculosis Outbreaks
    7. Epidemiological Burden and Trends
    8. Interventions against Tuberculosis
    9. Research and Development
    10. Summary of Cost-Effectiveness Analyses
    11. Tuberculosis Infection, Disease, and Death
15. 20. Vaccine–Preventable Diseases
    1. Improving the Costs and Cost-Effectiveness of Immunization Programs

Global Burden of Disease and Risk Factors

1. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
   1. Discussion and Conclusions
   2. Global and Regional Mortality in 2001

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
2. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Tobacco Use
3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
4. 7. Pillars of the Health System
   1. Financing
   2. Human Resources
   3. Management of Health Services
5. 6. Providing Interventions
6. 2. Success in Addressing Priorities

Chapter Presentations

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Cost-effectiveness of Interventions for Epidemic Tuberculosis in Low- and Middle-Income Countries
2. Cost-effectiveness of Interventions for Endemic Tuberculosis in Low- and Middle-Income Countries
3. Neglected Low-Cost Opportunities in South Asia: HIV/AIDS and Tuberculosis

Chapter 06. Product Development Priorities

1. Product Development for HIV/AIDS and TB, Public-Private Partnerships, 2004

Chapter 09. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?

1. Effective Interventions to Achieve the Tuberculosis MDG